Eastspring Investments - China Equity Fund - AS

For investors who want to maximise long-term total return by investing primarily in equity and equity-related instruments of corporations in the People's Republic of China

Fund objective

Add to watchlist
This Fund aims to maximize long-term total return by investing primarily in equity and equity-related instruments of corporations, which are incorporated in, or listed in, or operating principally from, or carrying on significant business in, or derive substantial revenue from, or whose Read more..

  • SGD 6.432
    NAV as of 17 Apr 2024
  • $0.01
    Daily $ Change
  • 0.14 %
    Daily % Change
  • Morningstar rating*
    31 Mar 2024

Fund performance

 

Returns

All data as at 29 February 2024

  1 m 3 m YTD 1 y 3 y
(p.a)
5 y
(p.a)
10 y
(p.a)
Since inception
(p.a)
Bid-Bid 7.9% -7.4% -3.1% -29.3% -29.0% -13.1% -3.3% -3.3%
Offer-Bid 2.5% -12.1% -8.0% -32.8% -30.2% -14.0% -3.8% -3.7%
Benchmark 9.4% -4.1% -1.1% -13.8% -19.6% -5.6% 1.6% 1.2%

(p.a.): per annum. Source: Eastspring Investments (Singapore) Limited. Returns are based in share class currency and computed on bid-bid basis with net income reinvested, if any. Offer-bid is inclusive of sales charge which is subject to changes. Since inception returns for periods less than a year are not annualised. The benchmark for the hedged share classes, if any, is also calculated on a hedged basis. Calendar year returns are based on the share class performance for the year, and if the share class was incepted during a particular year, the returns shown relate to the performance of the share class since its inception to the end of that calendar year. Wef July 2018, the monthly fund and benchmark returns calculated are aligned to the last NAV date of the fund for the month. Past performance information presented is not indicative of future performance.

Fund facts

  • Asset classEquity
  • ClassAS
  • Subscription methodCash,SRS
  • ISIN codeLU0588546209
  • Bloomberg tickerIOCHASS LX
  • Minimum initial investmentSGD 1,000+
  • Minimum subsequent investmentSGD 100
  • Inception date 07 Feb 2011
  • Base currencySGD
  • Initial sales chargeMax 5%
  • Annual management fees1.5%
  • Benchmark indexMSCI China 10/40 Index
  • Morningstar rating *
    31 Mar 2024

Footnote: + Subject to Distributor's terms and conditions.
*Rating should not be taken as a recommendation. © 2024 Morningstar. All rights reserved.

in insights

Know more
China: Uncovering opportunities within the medical beauty industry

in insights

Equity

China: Uncovering opportunities within the medical beauty industry

China is poised to become the world’s largest medical aesthetic service market ...

China: Navigating a policy driven market

in insights

Equity

China: Navigating a policy driven market

An understanding of China’s policy leanings is key to investing in its stock ...

Here comes the sun

in insights

Here comes the sun

Insurance: Another way to tap into China’s financial sector

in insights

Equity

Insurance: Another way to tap into China’s financial sector

The potential of China’s insurance sector is enormous, given the country’s ...